Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123431873 | 12343187 | 3 | F | 201508 | 20160719 | 20160506 | 20160722 | EXP | US-PFIZER INC-2016249147 | PFIZER | LENING, C.. ANTI-HMGCR NECROTIZING AUTOIMMUNE MYOPATHY PRESENTING AS ACUTE-ON-CHRONIC WEAKNESS. NEUROLOGY. 2016;86 (16 SUPPL):P3.129 | 67.00 | YR | M | Y | 0.00000 | 20160722 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123431873 | 12343187 | 1 | PS | ATORVASTATIN CALCIUM. | ATORVASTATIN CALCIUM | 1 | UNK | Y | 20702 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123431873 | 12343187 | 1 | Hyperlipidaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123431873 | 12343187 | OT |
| 123431873 | 12343187 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123431873 | 12343187 | Acute myocardial infarction | |
| 123431873 | 12343187 | Blood creatine phosphokinase increased | |
| 123431873 | 12343187 | Immune-mediated necrotising myopathy | |
| 123431873 | 12343187 | Rhabdomyolysis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |